NCT05130437: A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 50 planned
- Started
- 9 Nov 2021
- Primary completion
- 4 Dec 2029
- Arms
- mRNA-3927
- Results
- None posted
- 9 Nov 2021: Trial started
- 23 Nov 2021: Trial registered